{"pub": "yahoo", "url": "https://news.yahoo.com/opioid-companies-reach-tentative-260m-settlement-just-landmark-144900819.html", "downloaded_at": "2019-10-22 13:28:03.097373+00:00", "title": "Opioid companies reach tentative $260M settlement just before landmark trial in Ohio", "language": "en", "text": "Opioid companies reach tentative $260M settlement just before landmark trial in Ohio originally appeared on abcnews.go.com\n\nHours before a landmark opioid trial was set to start in an Ohio courthouse, major drug distributors and a manufacturer agreed to a tentative settlement, according to lawyers representing the thousands of communities involved in the case.\n\nThe settlement deal totals $260 million, according to a source familiar with the matter.\n\nThe settlement agreement between opioid drug distributors Cardinal Health, McKesson and Amerisource Bergen, as well as manufacturer Teva, \"will make significant progress to abate the epidemic by providing resources for and applying funds directly to necessary opioid-recovery programs,\" attorneys Paul J. Hanly Jr., Paul T. Farrell Jr. and Joe Rice, the executive committee co-leads from the National Prescription Opiate Litigation, said in a statement.\n\n(MORE: Johnson & Johnson to pay $20.4 million as part of Ohio opioid lawsuits settlement)\n\nThe preliminary settlement will resolve a majority of the cases brought against the four drug industry giants.\n\nCuyahoga and Summit Counties in Ohio are the first of the more than 2,700 communities as part of the National Prescription Opiate Litigation to go to trial, which was set to take place on Monday.\n\nPHOTO: U.S. District Judge Dan A. Polster in his courtroom at the Carl B. Stokes U.S. Courthouse, in Cleveland, Ohio, Jan. 29, 2018. (The New York Times via Redux, FILE) More\n\nThe attorneys, who represent Cuyahoga and Summit Counties, added that the communities have \"tirelessly investigated, litigated, and prepared for the bellwether trial that would have begun today if not for this agreement. In doing so, the communities revealed facts about the roles of the opioid industry that created and fueled the opioid epidemic.\"\n\nAlso during this process, \"we learned that this country\u2019s pharmacy system has played a greater role in the opioid epidemic than previously realized,\" the attorneys claimed, adding that the two counties will continue to \"litigate against pharmacy defendants.\"\n\n(MORE: Purdue Pharma files for bankruptcy as part of opioid crisis lawsuits)\n\nA group of attorneys general including Josh Stein of North Carolina, Herbert Slatery of Tennessee, Josh Shapiro of Pennsylvania and Ken Paxton of Texas released a joint statement following the news of the settlement in Ohio, calling it an \"important step that allows us to move forward to finalize the global settlement framework.\"\n\n\"People in every corner of the country have been hurt by this crisis, and it is critical that settlement funds be distributed fairly across states, cities, and counties and used wisely to combat the crisis,\" the statement said.\n\nIt added that the \"global resolution\" they are working on will ensure \"that these companies change their business practices to prevent a public health crisis like this from ever happening again.\"\n\nPHOTO: A pedestrian passes a McKesson sign on an office building in San Francisco. (Jeff Chiu/AP, FILE) More\n\nIn a joint statement, Cardinal Health, McKesson and Amerisource Bergen said they have \"agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation. With this settlement agreed upon, the companies and the other parties will now continue the work toward a global resolution.\"\n\n\"While the companies strongly dispute the allegations made by the two counties, they believe settling the bellwether trial is an important stepping stone to achieving a global resolution and delivering meaningful relief,\" the statement added. \"The companies expect settlement funds to be used in support of initiatives to combat the opioid epidemic, including treatment, rehabilitation, mental health and other important efforts.\"", "description": "Hours before a landmark opioid trial was set to start in an Ohio courthouse, major drug distributors and a manufacturer agreed to a tentative settlement, according to lawyers representing the thousands of communities involved in the case.  The settlement agreement between opioid drug distributors Cardinal", "authors": ["Catherine Thorbecke", "Aaron Katersky"], "top_image": "https://s.yimg.com/uu/api/res/1.2/Q0BsUzkvGDDZ_4I0MYxWVA--~B/aD01NTg7dz05OTI7c209MTthcHBpZD15dGFjaHlvbg--/http://media.zenfs.com/en_us/gma/us.abcnews.go.com/courthouse-cleveland-rt-ps-191021_hpMain_16x9_992.jpg", "published_at": "2019-10-21"}